Mescalin (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Mescalin" in German language version.

Last modified:

Ref.Un. Ref.Website
Global rank German rank
5th place
7th place
2nd place
3rd place
3,273rd place
3,588th place
low place
low place
774th place
63rd place
2,800th place
167th place
low place
4,640th place
443rd place
23rd place
low place
low place
366th place
1,286th place
low place
low place
low place
low place
1st place
1st place
low place
low place
1,764th place
109th place

caymanchem.com (Global: low place; German: 4,640th place)

digitale-sammlungen.de (Global: 443rd place; German: 23rd place)

  • Ueber Pellote. Ein Beitrag zur pharmakologischen Kenntniss der Cacteen. In: Archiv für experimentelle Pathologie und Pharmakologie. Band 34, 1894, S. 65–86 (Digitalisat, doi:10.1007/bf01864855); Ueber Pellote. Beiträge zur chemischen und pharmakologischen Kenntniss der Cacteen. Zweite Mittheilung. In: Archiv für experimentelle Pathologie und Pharmakologie. Band 40, 1898, S. 385–429 (Digitalisat doi:10.1007/BF01825267).

doi.org (Global: 2nd place; German: 3rd place)

  • T. Passie, U. Benzenhöfer: MDA, MDMA, and other “mescaline-like” substances in the US military’s search for a truth drug (1940s to 1960s). In: Drug testing and analysis. Band 10, Nummer 1, Januar 2018, S. 72–80, doi:10.1002/dta.2292, PMID 28851034 (Review).
  • L. Lewin: Ueber Anhalonium Lewinii. In: Archiv für Experimentelle Pathologie und Pharmakologie. Band 24, 1888, S. 401–411, doi:10.1007/bf01923627.
  • Ueber Pellote. Ein Beitrag zur pharmakologischen Kenntniss der Cacteen. In: Archiv für experimentelle Pathologie und Pharmakologie. Band 34, 1894, S. 65–86 (Digitalisat, doi:10.1007/bf01864855); Ueber Pellote. Beiträge zur chemischen und pharmakologischen Kenntniss der Cacteen. Zweite Mittheilung. In: Archiv für experimentelle Pathologie und Pharmakologie. Band 40, 1898, S. 385–429 (Digitalisat doi:10.1007/BF01825267).
  • Ernst Späth: Über die Anhalonium-Alkaloide: I. Anhalin und Mezcalin. In: Monatsh. Chem. 40, Nr. 2, 1919, S. 129–154; doi:10.1007/BF01524590.
  • O. Ogunbodede, D. McCombs, K. Trout, P. Daley, M. Terry: New mescaline concentrations from 14 taxa/cultivars of Echinopsis spp. (Cactaceae) (“San Pedro”) and their relevance to shamanic practice. In: Journal of ethnopharmacology. Band 131, Nummer 2, September 2010, S. 356–362, doi:10.1016/j.jep.2010.07.021, PMID 20637277.
  • Yohei Hashimoto, Kazuko Kawanishi, Masataka Moriyasu: Forensic Chemistry of Alkaloids by Chromatographic Analysis. In: The Alkaloids: Chemistry and Pharmacology. Band 32, 1988, S. 40 (doi:10.1016/S0099-9598(08)60215-1).
  • Keeper Trout: Cactus Chemistry by Species, 2014. doi:10.13140/RG.2.1.4715.8886.
  • Bonnie Glass-Coffin: Shamanism and San Pedro through Time: Some Notes on the Archaeology, History, and Continued Use of an Entheogen in Northern Peru. In: Anthropology of Consciousness. Band 21, Nr. 1, März 2010, S. 58–82, doi:10.1111/j.1556-3537.2010.01021.x.
  • Hesham R. El-Seedi, Peter A. G. M. De Smet, Olof Beck, Göran Possnert, Jan G. Bruhn: Prehistoric peyote use: Alkaloid analysis and radiocarbon dating of archaeological specimens of Lophophora from Texas. In: Journal of Ethnopharmacology. Band 101, Nr. 1, 3. Oktober 2005, S. 238–242, doi:10.1016/j.jep.2005.04.022.
  • A. Rickli, O. D. Moning, M. C. Hoener, M. E. Liechti: Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens. In: European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. Band 26, Nummer 8, August 2016, S. 1327–1337; doi:10.1016/j.euroneuro.2016.05.001, PMID 27216487.
  • D. E. Nichols: Psychedelics. In: Pharmacological reviews. Band 68, Nummer 2, April 2016, S. 264–355; doi:10.1124/pr.115.011478, PMID 26841800, PMC 4813425 (freier Volltext) (Review).
  • K. D. Charalampous, K. E. Walker, John Kinross-Wright: Metabolic fate of mescaline in man. In: Psychopharmacologia. Bd. 9, 1966, S. 48–63; doi:10.1007/BF00427703.
  • Teri S. Krebs, Pål-Ørjan Johansen, Lin Lu: Psychedelics and Mental Health: A Population Study. In: PLoS ONE. Bd. 8, 2013, S. e63972, doi:10.1371/journal.pone.0063972.
  • J. P. Finberg: Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release. In: Pharmacology & therapeutics. Band 143, Nummer 2, August 2014, S. 133–152, doi:10.1016/j.pharmthera.2014.02.010, PMID 24607445 (Review).
  • D. I. Brierley, C. Davidson: Developments in harmine pharmacology: implications for ayahuasca use and drug-dependence treatment. In: Progress in neuro-psychopharmacology & biological psychiatry. Band 39, Nummer 2, Dezember 2012, S. 263–272, doi:10.1016/j.pnpbp.2012.06.001, PMID 22691716 (Review).
  • R. S. Gable: Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. In: Addiction. Band 102, Nummer 1, Januar 2007, S. 24–34, doi:10.1111/j.1360-0443.2006.01652.x, PMID 17207120 (Review).

druglibrary.org (Global: low place; German: low place)

erowid.org (Global: 3,273rd place; German: 3,588th place)

eve-rave.net (Global: low place; German: low place)

gesetze-im-internet.de (Global: 1,764th place; German: 109th place)

nih.gov (Global: 5th place; German: 7th place)

ncbi.nlm.nih.gov

  • T. Passie, U. Benzenhöfer: MDA, MDMA, and other “mescaline-like” substances in the US military’s search for a truth drug (1940s to 1960s). In: Drug testing and analysis. Band 10, Nummer 1, Januar 2018, S. 72–80, doi:10.1002/dta.2292, PMID 28851034 (Review).
  • O. Ogunbodede, D. McCombs, K. Trout, P. Daley, M. Terry: New mescaline concentrations from 14 taxa/cultivars of Echinopsis spp. (Cactaceae) (“San Pedro”) and their relevance to shamanic practice. In: Journal of ethnopharmacology. Band 131, Nummer 2, September 2010, S. 356–362, doi:10.1016/j.jep.2010.07.021, PMID 20637277.
  • A. T. Shulgin, M. F. Carter: Centrally active phenethylamines. In: Psychopharmacology communications. Band 1, Nummer 1, 1975, S. 93–98, PMID 1223994.
  • C. Gambelunghe, R. Marsili, K. Aroni, M. Bacci, R. Rossi: GC-MS and GC-MS/MS in PCI mode determination of mescaline in peyote tea and in biological matrices. In: J Forensic Sci. Bd. 58, Nr. 1, Januar 2013, S. 270–278, PMID 22900815.
  • L. A. Nisbet, F. M. Wylie, B. K. Logan, K. S. Scott: Gas Chromatography-Mass Spectrometry Method for the Quantitative Identification of 23 New Psychoactive Substances in Blood and Urine. In: J Anal Toxicol. Bd. 43, Nr. 5, 1. Juni 2019, S. 346–352, PMID 30698723.
  • S. Yang, Y. Shi, Z. Chen, M. Chen, X. Liu, W. Liu, M. Su, B. Di: Detection of mescaline in human hair samples by UPLC-MS/MS: Application to 19 authentic forensic cases. In: J Chromatogr B Analyt Technol Biomed Life Sci. Bd. 1195, 15. April 2022, S. 123202, PMID 35248899.
  • A. Rickli, O. D. Moning, M. C. Hoener, M. E. Liechti: Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens. In: European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology. Band 26, Nummer 8, August 2016, S. 1327–1337; doi:10.1016/j.euroneuro.2016.05.001, PMID 27216487.
  • D. E. Nichols: Psychedelics. In: Pharmacological reviews. Band 68, Nummer 2, April 2016, S. 264–355; doi:10.1124/pr.115.011478, PMID 26841800, PMC 4813425 (freier Volltext) (Review).
  • J. H. Halpern, H. G. Pope: Hallucinogen persisting perception disorder: what do we know after 50 years? In: Drug and alcohol dependence. Band 69, Nummer 2, März 2003, S. 109–119, PMID 12609692 (Review).
  • F. Sjöqvist: Psychotropic drugs (2): Interaction between monoamine oxidase (MAO) inhibitors and other substances. In: Proceedings of the Royal Society of Medicine. Band 58, Nummer 11 Part 2, November 1965, S. 967–978, PMID 4952963, PMC 1898666 (freier Volltext) (Review).
  • M. G. Livingston, H. M. Livingston: Monoamine oxidase inhibitors: An update on drug interactions. In: Drug safety. Band 14, Nummer 4, April 1996, S. 219–227, PMID 8713690 (Review).
  • J. P. Finberg: Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release. In: Pharmacology & therapeutics. Band 143, Nummer 2, August 2014, S. 133–152, doi:10.1016/j.pharmthera.2014.02.010, PMID 24607445 (Review).
  • D. I. Brierley, C. Davidson: Developments in harmine pharmacology: implications for ayahuasca use and drug-dependence treatment. In: Progress in neuro-psychopharmacology & biological psychiatry. Band 39, Nummer 2, Dezember 2012, S. 263–272, doi:10.1016/j.pnpbp.2012.06.001, PMID 22691716 (Review).
  • R. S. Gable: Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. In: Addiction. Band 102, Nummer 1, Januar 2007, S. 24–34, doi:10.1111/j.1360-0443.2006.01652.x, PMID 17207120 (Review).

chem.nlm.nih.gov

pubchem.ncbi.nlm.nih.gov

openedition.org (Global: 366th place; German: 1,286th place)

books.openedition.org

  • Laura Larco: Archivo Arquidiocesano de Trujillo Sección Idolatrías. (Años 1768–1771). In: Más allá de los encantos: Documentos históricos y etnografía contemporánea sobre extirpación de idolatrías en Trujillo (siglos XVIII-XX) (= Travaux de l’IFEA). Institut français d’études andines, Lima 2015, ISBN 978-2-8218-4453-7, S. 67–87 (openedition.org [abgerufen am 15. April 2022]).

rgable.net (Global: low place; German: low place)

  • Robert Gable: Drug Toxicity. Abgerufen am 17. Februar 2011 (englisch).

sacredcacti.com (Global: low place; German: low place)

sigmaaldrich.com (Global: 774th place; German: 63rd place)

swgdrug.org (Global: low place; German: low place)

thieme.de (Global: 2,800th place; German: 167th place)

roempp.thieme.de

web.archive.org (Global: 1st place; German: 1st place)